WASHINGTON, Dec 5 (Reuters) - U.S. health regulators on Monday said a CardioMEMs implant for treating heart failure met its main safety and effectiveness targets but warned of potential bias in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback